23andMe special committee again rejects CEO Wojcicki’s take-private offer

23andMe’s special committee of independent directors on Monday rejected CEO Anne Wojcicki’s proposal to take the distressed genetic testing company private.

Posted in Tech | Tagged | Comments Off on 23andMe special committee again rejects CEO Wojcicki’s take-private offer

Huawei charts cautious global comeback with ultra-expensive phones — but major challenges remain

Huawei has launched the Mate XS and Mate XT trifold outside of China as it charts a cautious path back into international markets.

Posted in Tech | Tagged | Comments Off on Huawei charts cautious global comeback with ultra-expensive phones — but major challenges remain

AMD’s Radeon RX 9070 and 9070 XT Deliver 20% to 40% More Power, Challenging NVIDIA

The $549 and $599 price points put these GPUs in intense competition with NVIDIA’s RTX 50-series. Plus, AMD committed to an AI telecom solution layer at Mobile World Congress.

Posted in Tech | Tagged | Comments Off on AMD’s Radeon RX 9070 and 9070 XT Deliver 20% to 40% More Power, Challenging NVIDIA

People are using Super Mario to benchmark AI now

At least we can watch AI play Mario.
© 2024 TechCrunch. All rights reserved. For personal use only.

Posted in Tech | Tagged | Comments Off on People are using Super Mario to benchmark AI now

General Catalyst loses three top investors as the firm expands beyond venture, contemplates IPO

Three key investors have left General Catalyst amidst a series of recent changes at the firm, which now describes itself as an “investment and transformation company,” TechCrunch has learned. The departed managing directors include Deep Nishar and Kyle Doherty, who co-led General Catalyst’s late-stage strategy known as Endurance, and Adam Valkin, one of the three […]
© 2024 TechCrunch. All rights reserved. For personal use only.

Posted in Tech | Tagged | Comments Off on General Catalyst loses three top investors as the firm expands beyond venture, contemplates IPO

Trump’s FDA Cuts Are Putting Drug Development at Risk

New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug research and delay FDA approvals.

Posted in Business | Tagged | Comments Off on Trump’s FDA Cuts Are Putting Drug Development at Risk

Elon Musk’s $1 Spending Limit Is Paralyzing Federal Agencies

The DOGE-mandated credit card freeze is delaying shipments of critical supplies, stalling travel, and stopping employees from doing their jobs.

Posted in Business | Tagged | Comments Off on Elon Musk’s $1 Spending Limit Is Paralyzing Federal Agencies

AI cloud provider CoreWeave files for IPO

CoreWeave, which counts on Microsoft for close to two-thirds of its revenue, is headed for the public market.

Posted in Tech | Tagged | Comments Off on AI cloud provider CoreWeave files for IPO

MWC 2025: Samsung’s Midrange Galaxy A Series Gets Gen AI & Longer Battery Life, Expands AI Accessibility

The Galaxy A56 5G, Galaxy A36 5G, and Galaxy A26 5G will use Samsung’s One UI 7 interface revamp.

Posted in Tech | Tagged | Comments Off on MWC 2025: Samsung’s Midrange Galaxy A Series Gets Gen AI & Longer Battery Life, Expands AI Accessibility

Singapore arrests alleged Nvidia chip smugglers

Singapore just arrested 3 men for allegedly smuggling Nvidia chips.
© 2024 TechCrunch. All rights reserved. For personal use only.

Posted in Tech | Tagged | Comments Off on Singapore arrests alleged Nvidia chip smugglers